Full Press Release Details
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing.
SLDB
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing
Key Takeaway: Solid Biosciences Reports Inducement Grants Under Nasdaq Listing
Price reaction · baseline $6.77 (2022-12-02 close) · clean, no other SLDB news in the window
day 0 close · peak
-4.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma